Voya Investment Management LLC lifted its stake in Imperva Inc (NYSE:IMPV) by 26.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,347 shares of the software maker’s stock after purchasing an additional 3,167 shares during the period. Voya Investment Management LLC’s holdings in Imperva were worth $734,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in IMPV. KCG Holdings Inc. acquired a new stake in shares of Imperva in the first quarter valued at about $201,000. Amalgamated Bank acquired a new stake in shares of Imperva in the second quarter valued at about $206,000. Principal Financial Group Inc. acquired a new stake in shares of Imperva in the second quarter valued at about $223,000. Jane Street Group LLC acquired a new stake in shares of Imperva in the first quarter valued at about $224,000. Finally, Turner Investments LLC acquired a new stake in shares of Imperva in the second quarter valued at about $239,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Imperva Inc (IMPV) Position Increased by Voya Investment Management LLC” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.com-unik.info/2017/11/01/imperva-inc-impv-position-increased-by-voya-investment-management-llc.html.
Several analysts recently commented on the stock. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research note on Thursday, August 10th. KeyCorp restated a “hold” rating on shares of Imperva in a report on Tuesday, October 24th. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price for the company in a report on Tuesday, October 24th. Piper Jaffray Companies set a $58.00 target price on shares of Imperva and gave the company a “buy” rating in a report on Monday, August 28th. Finally, BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, August 22nd. One analyst has rated the stock with a sell rating, nine have issued a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $51.23.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is currently owned by corporate insiders.
Shares of Imperva Inc (IMPV) opened at 42.70 on Wednesday. The stock’s 50 day moving average is $43.38 and its 200-day moving average is $45.94. Imperva Inc has a one year low of $34.40 and a one year high of $52.40. The stock’s market capitalization is $1.44 billion.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
What are top analysts saying about Imperva Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva Inc and related companies.